000			01305 a2200385 4500
005			20250513152547.0
264		0	_c19981204
008			199812s 0 0 eng d
022			_a1071-9164
024	7		_a10.1016/s1071-9164(98)80014-6 _2doi
040			_aNLM _beng _cNLM
100	1		_aHennekens, C H
245	0	0	_aValidity versus generalizability in clinical trial design and conduct. _h[electronic resource]
260			_bJournal of cardiac failure _cSep 1998
300			_a239-41 p. _bdigital
500			_aPublication Type: Comment; Editorial
650	0	4	_aAdult
650	0	4	_aAge Distribution
650	0	4	_aCardiovascular Diseases _xclassification
650	0	4	_aClinical Trials as Topic _xmethods
650	0	4	_aEligibility Determination _xmethods
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMass Screening _xmethods
650	0	4	_aPatient Selection
650	0	4	_aRandomized Controlled Trials as Topic _xmethods
650	0	4	_aReproducibility of Results
650	0	4	_aResearch Design
650	0	4	_aSelection Bias
650	0	4	_aSex Distribution
700	1		_aBuring, J E
773	0		_tJournal of cardiac failure _gvol. 4 _gno. 3 _gp. 239-41
856	4	0	_uhttps://doi.org/10.1016/s1071-9164(98)80014-6 _zAvailable from publisher's website
999			_c9719492 _d9719492